T1	Participants 0 7	Patient
T2	Participants 53 68	cancer patients
T3	Participants 203 210	patient
T4	Participants 313 328	cancer patients
T5	Participants 468 476	Patients
T6	Participants 713 721	patients
T7	Participants 830 837	patient
T8	Participants 1020 1041	Thirty-seven patients
T9	Participants 1080 1117	(54% male; mean age 58.7 ± 9.5 years;
T10	Participants 1340 1351	both groups
T11	Participants 1401 1418	groups (P > 0.05)
T12	Participants 1821 1829	patients
